Church & Dwight (CHD) 10-Q 30 Apr 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Apr. 28, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Trading Symbol	CHD
Entity Registrant Name	CHURCH & DWIGHT CO., INC.
Entity Central Index Key	0000313927
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	1-10585
Entity Tax Identification Number	13-4996950
Entity Address, Address Line One	500 Charles Ewing Boulevard
Entity Address, City or Town	Ewing
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	08628
City Area Code	609
Local Phone Number	806-1200
Entity Incorporation, State or Country Code	DE
Title of 12(b) Security	Common Stock, $1 par value
Security Exchange Name	NYSE
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding		245,892,719

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) shares in Millions, $ in Millions		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Net Sales	[1]	$ 1,165.2	$ 1,044.7
Cost of sales		633.2	573.9
Gross Profit		532	470.8
Marketing expenses		96.4	98.1
Selling, general and administrative expenses		121	131.9
Income from Operations		314.6	240.8
Equity in earnings of affiliates		1.6	1.7
Investment earnings		0.1	0.5
Other income (expense), net		(0.6)	(0.1)
Interest expense		(16.3)	(17.8)
Income before Income Taxes	[2]	299.4	225.1
Income taxes		69.6	49.4
Net Income		$ 229.8	$ 175.7
Weighted average shares outstanding - Basic		245.6	246.1
Weighted average shares outstanding - Diluted		251	251.9
Net income per share - Basic		$ 0.94	$ 0.71
Net income per share - Diluted		0.92	0.70
Cash dividends per share		$ 0.24	$ 0.23
[1]	Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $3.0 and $2.3 for the three months ended March 31, 2020 and March 31, 2019, respectively .
[2]	In determining income before income taxes, interest expense, investment earnings and certain aspects of other income and expense were allocated among segments based upon each segment’s relative income from operations.

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net Income	$ 229.8	$ 175.7
Other comprehensive income, net of tax:
Foreign exchange translation adjustments	(13)	1.8
Income (loss) from derivative agreements	(19.7)	(7.7)
Other comprehensive income (loss)	(32.7)	(5.9)
Comprehensive income	$ 197.1	$ 169.8

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Current Assets
Cash and cash equivalents	$ 1,046.6	$ 155.7
Accounts receivable, less allowances of $3.7 and $2.4	353.5	356.4
Inventories	395.7	417.4
Other current assets	33	26.9
Total Current Assets	1,828.8	956.4
Property, Plant and Equipment, Net	566.7	573
Equity Investment in Affiliates	10	9.7
Trade Names and Other Intangibles, Net	2,721.6	2,750
Goodwill	2,078.2	2,079.5
Other Assets	280.6	288.8
Total Assets	7,485.9	6,657.4
Current Liabilities
Short-term borrowings	971.9	252.9
Accounts payable and accrued expenses	741.2	831.9
Income taxes payable	55.9	7.5
Total Current Liabilities	1,769	1,092.3
Long-term Debt	1,810.8	1,810.2
Deferred Income Taxes	580.2	579.6
Deferred and Other Long-term Liabilities	343.1	315.5
Business Acquisition Liabilities	165	192
Total Liabilities	4,668.1	3,989.6
Commitments and Contingencies
Stockholders' Equity
Preferred Stock, $1.00 par value, Authorized 2,500,000 shares; none issued	0	0
Common Stock, $1.00 par value, Authorized 600,000,000 shares and 292,855,100 shares issued as of March 31, 2020 and December 31, 2019	292.8	292.8
Additional paid-in capital	295.7	295.5
Retained earnings	4,408.2	4,237.4
Accumulated other comprehensive loss	(99.4)	(66.7)
Common stock in treasury, at cost: 47,099,092 shares as of March 31, 2020 and 47,439,300 shares as of December 31, 2019	(2,079.5)	(2,091.2)
Total Stockholders' Equity	2,817.8	2,667.8
Total Liabilities and Stockholders' Equity	$ 7,485.9	$ 6,657.4

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Accounts receivable, allowances	$ 3.7	$ 2.4
Preferred Stock, par value	$ 1	$ 1
Preferred Stock, Authorized	2,500,000	2,500,000
Preferred Stock, issued	0	0
Common Stock, par value	$ 1	$ 1
Common Stock, Authorized	600,000,000	600,000,000
Common Stock, shares issued	292,855,100	292,855,100
Common stock in treasury, shares	47,099,092	47,439,300

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash Flow From Operating Activities
Net Income	$ 229.8	$ 175.7
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense	16	15.8
Amortization expense	30.2	22.8
Deferred income taxes	8.1	2.8
Equity in net earnings of affiliates	(1.6)	(1.7)
Distributions from unconsolidated affiliates	1.3	0.7
Non-cash compensation expense	2.7	2.4
Gain on sale of assets	(3)	0
Other	2.1	(0.7)
Change in assets and liabilities:
Accounts receivable	(8.3)	(36)
Inventories	15.2	(15.9)
Other current assets	(5)	0.5
Accounts payable and accrued expenses	(74)	(59.2)
Income taxes payable	54	34.3
Change in fair value of business acquisition liabilities	(27)	0
Other operating assets and liabilities, net	(4)	(3.6)
Net Cash Provided By Operating Activities	236.5	137.9
Cash Flow From Investing Activities
Additions to property, plant and equipment	(16.8)	(11.7)
Proceeds from sale of assets	7	0
Other	(1.6)	(0.7)
Net Cash Used In Investing Activities	(11.4)	(12.4)
Cash Flow From Financing Activities
Long-term debt (repayments)	0	(300)
Short-term debt borrowings, net of (repayments)	719.9	98
Proceeds from stock options exercised	9.3	15.1
Payment of cash dividends	(59)	(55.9)
Purchase of treasury stock	0	(100)
Deferred financing and other	(0.1)	(1.5)
Net Cash Provided By (Used In) Financing Activities	670.1	(344.3)
Effect of exchange rate changes on cash and cash equivalents	(4.3)	0
Net Change In Cash and Cash Equivalents	890.9	(218.8)
Cash and Cash Equivalents at Beginning of Period	155.7	316.7
Cash and Cash Equivalents at End of Period	1,046.6	97.9
Cash paid during the period for:
Interest (net of amounts capitalized)	21.9	21.8
Income taxes	7.4	12.3
Supplemental disclosure of non-cash investing activities:
Property, plant and equipment expenditures included in Accounts Payable	$ 7	$ 6

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2018	$ 2,453.8	$ 292.8	$ (1,898.8)	$ 280.8	$ 3,832.6	$ (53.6)
Beginning Balance (in shares) at Dec. 31, 2018		292.8	(46)
Adoption of new accounting pronouncements	13	$ 0	$ 0	0	13	0
Net Income	175.7	0	0	0	175.7	0
Other comprehensive income (loss)	(5.9)	0	0	0	0	(5.9)
Cash dividends	(55.9)	0	0	0	(55.9)	0
Stock purchases	(100)	$ 0	$ (100)	0	0	0
Stock purchases (in shares)		0	(1.5)
Stock based compensation expense and stock option plan transactions	18.6	$ 0	$ 18.1	0.5	0	0
Stock based compensation expense and stock option plan transactions (in shares)		0	0.7
Ending Balance at Mar. 31, 2019	2,499.3	$ 292.8	$ (1,980.7)	281.3	3,965.4	(59.5)
Ending Balance (in shares) at Mar. 31, 2019		292.8	(46.8)
Beginning Balance at Dec. 31, 2019	2,667.8	$ 292.8	$ (2,091.2)	295.5	4,237.4	(66.7)
Beginning Balance (in shares) at Dec. 31, 2019		292.8	(47.4)
Net Income	229.8	$ 0	$ 0	0	229.8	0
Other comprehensive income (loss)	(32.7)	0	0	0	0	(32.7)
Cash dividends	(59)	0	0	0	(59)	0
Stock based compensation expense and stock option plan transactions	11.9	$ 0	$ 11.7	0.2	0	0
Stock based compensation expense and stock option plan transactions (in shares)		0	0.3
Ending Balance at Mar. 31, 2020	$ 2,817.8	$ 292.8	$ (2,079.5)	$ 295.7	$ 4,408.2	$ (99.4)
Ending Balance (in shares) at Mar. 31, 2020		292.8	(47.1)

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	1. Basis of Presentation These condensed consolidated financial statements have been prepared by Church & Dwight Co., Inc. (the “Company”). In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position and results of operations and cash flows for all periods presented have been made. Results of operations for interim periods may not be representative of results to be expected for the full year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 (the “Form 10-K”). The Company incurred research and development expenses in the first quarter of 2020 and 2019 of $21.7 and $20.7, respectively. These expenses are included in selling, general and administrative (“SG&A”) expenses.

New Accounting Pronouncements

New Accounting Pronouncements	3 Months Ended
	Mar. 31, 2020
Accounting Changes And Error Corrections [Abstract]
New Accounting Pronouncements	2. New Accounting Pronouncements Recently Adopted Accounting Pronouncements In June 2016, the FASB issued accounting guidance (with subsequent targeted amendments) which modifies the measurements of expected credit losses for certain financial instruments and financial assets, including trade receivables. This guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. The standard did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows. In March 2020, the Financial Accounting Standards Board (“FASB”) issued new accounting guidance intended to provide temporary optional expedients and exceptions to the US GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates. This guidance is effective beginning on March 12, 2020, and the Company may apply the amendments prospectively to contract modifications made or relationships entered into or evaluated through December 31, 2022. The Company is currently evaluating contracts and the optional expedients provided by the new standard. There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

Inventories

Inventories	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
Inventories	3 . Inventories Inventories consist of the following: March 31, December 31, 2020 2019 Raw materials and supplies $ 85.0 $ 85.9 Work in process 30.4 29.0 Finished goods 280.3 302.5 Total $ 395.7 $ 417.4

Property, Plant and Equipment,

Property, Plant and Equipment, Net ("PP&E")	3 Months Ended
	Mar. 31, 2020
Property Plant And Equipment [Abstract]
Property, Plant and Equipment, Net ("PP&E")	4 . Property, Plant and Equipment, Net (“PP&E”) PP&E consists of the following: March 31, December 31, 2020 2019 Land $ 27.7 $ 27.8 Buildings and improvements 256.0 255.4 Machinery and equipment 739.4 737.4 Software 98.2 96.7 Office equipment and other assets 78.9 76.0 Construction in progress 72.0 72.9 Gross PP&E 1,272.2 1,266.2 Less accumulated depreciation and amortization 705.5 693.2 Net PP&E $ 566.7 $ 573.0 Three Months Ended March 31, March 31, 2020 2019 Depreciation and amortization on PP&E $ 16.0 $ 15.8

Earnings Per Share ("EPS")

Earnings Per Share ("EPS")	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Earnings Per Share ("EPS")	5 . Earnings Per Share (“EPS”) Basic EPS is calculated based on income available to holders of the Company’s common stock (“Common Stock”) and the weighted average number of shares outstanding during the reported period. Diluted EPS includes additional dilution from potential Common Stock issuable pursuant to the exercise of outstanding stock options. The following table sets forth a reconciliation of the weighted average number of shares of Common Stock outstanding to the weighted average number of shares outstanding on a diluted basis: Three Months Ended March 31, March 31, 2020 2019 Weighted average common shares outstanding - basic 245.6 246.1 Dilutive effect of stock options 5.4 5.8 Weighted average common shares outstanding - diluted 251.0 251.9 Antidilutive stock options outstanding 1.5 0.1

Stock Based Compensation Plans

Stock Based Compensation Plans	3 Months Ended
	Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Based Compensation Plans	6 . Stock Based Compensation Plans The following table provides a summary of option activity: Weighted Average Weighted Remaining Average Contractual Aggregate Exercise Term Intrinsic Options Price (in Years) Value Outstanding at December 31, 2019 14.0 $ 43.23 Exercised (0.3 ) 29.31 Outstanding at March 31, 2020 13.7 $ 43.62 5.2 $ 300.3 Exercisable at March 31, 2020 8.4 $ 34.47 3.6 $ 250.5 The following table provides information regarding the intrinsic value of stock options exercised and stock compensation expense related to stock option awards: Three Months Ended March 31, March 31, 2020 2019 Intrinsic Value of Stock Options Exercised $ 14.3 $ 24.1 Stock Compensation Expense Related to Stock Option Awards $ 2.7 $ 2.3

Share Repurchases

Share Repurchases	3 Months Ended
	Mar. 31, 2020
Payments For Repurchase Of Equity [Abstract]
Share Repurchases	7. Share Repurchases On November 1, 2017, the Board authorized a share repurchase program, under which the Company may repurchase up to $500.0 in shares of Common Stock (the “2017 Share Repurchase Program”). The 2017 Share Repurchase Program does not have an expiration. The Company also continued its evergreen share repurchase program, authorized by the Board on January 29, 2014, under which the Company may repurchase, from time to time, Common Stock to reduce or eliminate dilution associated with issuances of Common Stock under the Company’s incentive plans The Company did not repurchase any shares of its common stock in the first quarter of 2020. As a result of the Company’s stock repurchases in recent years, there remains $210.0 of share repurchase availability under the 2017 Share Repurchase Program as of March 31, 2020.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	8. Fair Value Measurements The following table presents the carrying amounts and estimated fair values of the Company’s other financial instruments at March 31, 2020 and December 31, 2019: March 31, 2020 December 31, 2019 Input Carrying Fair Carrying Fair Level Amount Value Amount Value Financial Assets: Cash equivalents Level 1 $ 963.0 $ 963.0 $ 65.3 $ 65.3 Financial Liabilities: Short-term borrowings Level 2 971.9 971.9 252.9 252.9 Term loan due May 1, 2022 Level 2 300.0 300.0 300.0 300.0 2.45% Senior notes due August 1, 2022 Level 2 299.8 296.9 299.8 302.6 2.875% Senior notes due October 1, 2022 Level 2 399.9 400.6 399.9 408.2 3.15% Senior notes due August 1, 2027 Level 2 424.7 424.8 424.7 438.9 3.95% Senior notes due August 1, 2047 Level 2 397.3 413.3 397.3 427.1 Business Acquisition Liabilities Level 3 165.0 165.0 206.2 206.2 Interest Rate Swap Lock Agreement asset (liability) Level 2 (66.4 ) (66.4 ) (29.5 ) (29.5 ) The Company recognizes transfers between input levels as of the actual date of the event. There were no transfers between input levels during the three months ended March 31, 2020. Refer to Note 2 in the Form 10-K for a description of the methods and assumptions used to estimate the fair value of each class of financial instruments reflected in the condensed consolidated balance sheets. The business acquisition liabilities represent the estimated fair value of additional future earn-outs payable for acquisitions of businesses that included earn-out clauses. The valuation of the contingent consideration is being evaluated on an ongoing basis and is based on management estimates and entity-specific assumptions which are considered Level 3 inputs. In the first quarter of 2020, the Company decreased the estimate of the contingent consideration liability for the Flawless Acquisition by $27.0 from $192.0 to $165.0 based on the revised valuation due to updated sales forecasts as well as the passage of time. The $27.0 reduction of SG&A expense was recorded within the Consumer Domestic and Consumer International Segments. The business acquisition liabilities for December 31, 2019 also includes a $14.2 liability for the Agro Acquisition. The Agro Acquisition earnout was finalized in December 2019 and the liability was paid in the second quarter of 2020. As of December 31, 2019 and March 31, 2020, the liability was recorded within Accounts Payable and Accrued Expenses. The interest rate swap lock agreements were used to hedge the risk of changes in the interest payments attributable to changes in the benchmark U.S. Dollar London Interbank Offered Rate (“LIBOR”) interest rate associated with anticipated issuances of debt. The liability increased by $ 36.9 during the first quarter of 2020 primarily due to lower current and projected interest rate s associated with the COVID-19 pandemic. The carrying amounts of accounts receivable, and accounts payable and accrued expenses, approximated estimated fair values as of March 31, 2020 and December 31, 2019.

Derivative Instruments and Risk

Derivative Instruments and Risk Management	3 Months Ended
	Mar. 31, 2020
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivative Instruments and Risk Management	9 . Derivative Instruments and Risk Management Changes in interest rates, foreign exchange rates, the price of the Common Stock and commodity prices expose the Company to market risk. The Company manages these risks by the use of derivative instruments, such as cash flow and fair value hedges, diesel and commodity hedge contracts, equity derivatives and foreign exchange forward contracts. The Company does not use derivatives for trading or speculative purposes. Refer to Note 3 in the Form 10-K for a discussion of each of the Company’s derivative instruments in effect as of December 31, 2019. The notional amount of a derivative instrument is the nominal or face amount used to calculate payments made on that instrument. Notional amounts are presented in the following table: Notional Notional Amount Amount March 31, 2020 December 31, 2019 Derivatives designated as hedging instruments Foreign exchange contracts $ 223.6 $ 216.0 Interest rate swap lock $ 300.0 $ 300.0 Diesel fuel contracts 7.0 gallons 4.8 gallons Commodities contracts 88.2 pounds 81.2 pounds Derivatives not designated as hedging instruments Equity derivatives $ 20.2 $ 22.1 Excluding the Interest Rate Swap Lock Agreement disclosed in Note 8, the fair values and amount of gain (loss) recognized in income and Other Comprehensive Income (“OCI”) associated with the derivative instruments disclosed above did not have a material impact on the Company’s condensed consolidated financial statements.

Acquisitions

Acquisitions	3 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Acquisitions	10. Acquisitions On May 1, 2019, the Company closed on its previously announced acquisition of the FLAWLESS hair removal business (the “Flawless Acquisition”) from Ideavillage Products Corporation (“Ideavillage”). The Company paid $475.0 at closing and may make an additional contingent consideration payment twelve-month three-year The fair values of the net assets acquired are set forth as follows: Trade name $ 447.3 Other intangible assets 121.8 Goodwill 87.9 Contingent consideration (182.0 ) Cash purchase price $ 475.0 As a result of the Company purchasing assets, the goodwill and other intangible assets associated with the Flawless Acquisition are deductible for U.S. tax purposes. The trade names and other intangible assets were valued using a discounted cash flow model. The life of the amortizable intangible assets recognized from the Flawless Acquisition ranges from 15 - 20 years. The goodwill is a result of expected synergies from combined operations of the acquisition and the Company. Pro forma results are not presented because the impact of the acquisition is not material to the Company’s consolidated financial results. The contingent liability is remeasured at each balance sheet date until the completion of the earn-out period. Subsequent to the date of the Flawless Acquisition, the Company decreased the estimate of the contingent consideration liability by $17.0 from $182.0 to $165.0 based on the revised valuation due to updated sales forecasts as well as the passage of time. Ideavillage will help support the business through a separate long-term transition services agreement.

Goodwill and Other Intangibles,

Goodwill and Other Intangibles, Net	3 Months Ended
	Mar. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangibles, Net	1 1 . Goodwill and Other Intangibles, Net The following table provides information related to the carrying value of all intangible assets, other than goodwill: March 31, 2020 December 31, 2019 Gross Amortization Gross Carrying Accumulated Period Carrying Accumulated Amount Amortization Net (Years) Amount Amortization Net Amortizable intangible assets: Trade Names $ 1,019.9 $ (229.2 ) $ 790.7 3-20 $ 1,025.8 $ (219.7 ) $ 806.1 Customer Relationships 584.8 (264.0 ) 320.8 15-20 584.8 (255.0 ) 329.8 Patents/Formulas 211.4 (76.0 ) 135.4 4-20 211.4 (73.0 ) 138.4 Non-Compete Agreement 0.0 0.0 0.0 5-10 0.4 (0.4 ) 0.0 Total $ 1,816.1 $ (569.2 ) $ 1,246.9 $ 1,822.4 $ (548.1 ) $ 1,274.3 Indefinite Lived Intangible Assets - Gross Carrying Amount March 31, December 31, 2020 2019 Trade Names $ 1,474.7 $ 1,475.7 Intangible amortization expense amounted to $24.5 and $17.6 for the first three months of 2020 and 2019, respectively. The Company estimates that intangible amortization expense will be approximately $98.0 in 2020 and approximately $96.0 to $88.0 annually over the next five years. During the first quarter of 2020, the Company sold its PERL WEISS® toothpaste brand in Germany with a tradename net book value of $2.7 and corresponding goodwill of $1.3 for cash proceeds of $7.0. The $3.0 gain associated with this transaction was recorded as a reduction of SG&A expense in the Consumer International Segment. Fair value for indefinite lived intangible assets was estimated based on a “relief from royalty” or “excess earnings” discounted cash flow method, which contains numerous variables that are subject to change as business conditions change, and therefore could impact fair values in the future. The key assumptions used in determining fair value are sales growth, profitability margins, tax rates and discount rates. The Company determined that the fair value of all other intangible assets for each of the years in the three-year period ended December 31, 2019 exceeded their respective carrying values based upon the forecasted cash flows and profitability. The Company considers all of its personal care brands fair value to substantially exceed their carrying value. However, in recent years the Company’s Trojan business, specifically the condom category, has not grown and competition has increased resulting in a potential reduction in cash flows. As a result, the Trojan business has experienced sales and profit declines that has eroded a portion of the excess between fair and carrying value, which could potentially result in an impairment of the tradename. The carrying value of the Trojan tradename is $176.4 million. As of December 31, 2019, fair value exceeded carrying value by 26%. Key assumptions used in the projections include discount rates of 9.5% in the U.S. and 11.5% internationally, growth assumptions of 0% to 2% and an average royalty rate of approximately 10%. This indefinite-lived intangible asset is susceptible to impairment risk. While management can and has implemented strategies to address the risk, including lowering the Company’s production costs, investing in new product ideas, and developing new creative advertising, significant changes in operating plans or adverse changes in the future could reduce the underlying cash flows used to estimate fair value. This could result in a decline in fair value that could trigger a future impairment charge of the tradename. As a result of the pandemic, c onsumers are stocking up on household staple products, such as laundry detergent, cat litter, bathroom cleaners, baking soda and personal care products such as vitamins and supplements and nasal hygiene products. However, sales of some of our personal care products have slowed due to retailer closures or reduced hours of or consumer capacity in their stores . The Company is monitoring the impact the virus and the associated governmental response is having on its customers and consumer demand , as well as the potential impact on the Company’s short and long term cash flows as it relates to its intangible asset carrying values . In addition, the Company’s Passport Food Safety business, under pressure as a result of the The carrying amount of goodwill is as follows: Consumer Consumer Specialty Domestic International Products Total Balance at December 31, 2019 $ 1,707.9 $ 235.6 $ 136.0 $ 2,079.5 Perl Weiss divestiture 0.0 (1.3 ) 0.0 (1.3 ) Balance at March 31, 2020 $ 1,707.9 $ 234.3 $ 136.0 $ 2,078.2 The result of the Company’s annual goodwill impairment test, performed in the beginning of the second quarter of 2019, determined that the estimated fair value substantially exceeded the carrying values of all reporting units. The determination of fair value contains numerous variables that are subject to change as business conditions change and therefore could impact fair value in the future. The Company has never incurred a goodwill impairment charge.

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	1 2 . Leases The Company leases certain manufacturing facilities, warehouses, office space, railcars and equipment. Leases with an initial term of twelve months or less are not recorded on the condensed consolidated balance sheet. All recorded leases are classified as operating leases and lease expense is recognized on a straight-line basis over the lease term. For leases beginning in 2019, lease components (base rental costs) are accounted for separately from the nonlease components (e.g., common-area maintenance costs). For leases that do not provide an implicit rate, the Company uses its estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. A summary of the Company’s lease information is as follows: March 31, December 31, Classification 2020 2019 Assets Right of use assets Other Assets $ 155.2 $ 150.7 Liabilities Current lease liabilities Accounts Payable and Accrued Expenses $ 16.5 $ 16.4 Long-term lease liabilities Deferred and Other Long-term Liabilities 148.6 144.0 Total lease liabilities $ 165.1 $ 160.4 Other information Weighted-average remaining lease term (years) 11.2 11.1 Weighted-average discount rate 4.9 % 4.9 % Three Months Three Months Ended Ended March 31, 2020 March 31, 2019 Statement of Income Lease cost (1) $ 6.6 $ 5.6 Other information Leased assets obtained in exchange for new lease liabilities (2) $ 10.2 $ 1.3 Cash paid for amounts included in the measurement of lease liabilities $ 6.2 $ 6.0 (1) Lease expense is included in cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The noncash component of lease expense for the first three months of 2020 and 2019 was $4.8 and $4.1, respectively, and is included in the Amortization caption in the condensed consolidated statement of cash flows. (2) In March 2020, the Company approved a capital project to purchase additional machinery and equipment at one of its leased manufacturing facilities. This led to a lease modification to include a renewal option that would extend the lease for an additional five years through 2029. The modification resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $7.3 recorded in the first quarter of 2020. The Company’s minimum annual rentals including reasonably assured renewal options under lease agreements are as follows: Operating Leases 2020 $ 17.5 2021 24.0 2022 21.6 2023 16.8 2024 15.6 2025 and thereafter 120.5 Total future minimum lease commitments 216.0 Less: Imputed Interest (50.9 ) Present value of lease liabilities $ 165.1

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	3 Months Ended
	Mar. 31, 2020
Payables And Accruals [Abstract]
Accounts Payable and Accrued Expenses	1 3 . Accounts Payable and Accrued Expenses Accounts payable and accrued expenses consist of the following: March 31, December 31, 2020 2019 Trade accounts payable $ 460.1 $ 473.3 Accrued marketing and promotion costs 123.9 138.1 Accrued wages and related benefit costs 37.6 96.5 Other accrued current liabilities 119.6 124.0 Total $ 741.2 $ 831.9

Short-Term Borrowings and Long-

Short-Term Borrowings and Long-Term Debt	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Short-Term Borrowings and Long-Term Debt	1 4 . Short-Term Borrowings and Long-Term Debt Short-term borrowings and long-term debt consist of the following: March 31, December 31, 2020 2019 Short-term borrowings Revolving credit agreement borrowings (a) $ 825.0 $ 0.0 Commercial paper issuances 144.1 248.6 Various debt due to international banks 2.8 4.3 Total short-term borrowings $ 971.9 $ 252.9 Long-term debt Term loan due May 1, 2022 300.0 300.0 2.45% Senior notes due August 1, 2022 300.0 300.0 Less: Discount (0.2 ) (0.2 ) 2.875% Senior notes due October 1, 2022 400.0 400.0 Less: Discount (0.1 ) (0.1 ) 3.15% Senior notes due August 1, 2027 425.0 425.0 Less: Discount (0.3 ) (0.3 ) 3.95% Senior notes due August 1, 2047 400.0 400.0 Less: Discount (2.7 ) (2.7 ) Debt issuance costs, net (10.9 ) (11.5 ) Net long-term debt $ 1,810.8 $ 1,810.2 (a) The Company is party to a credit agreement dated March 29, 2018, as amended (the “Credit Agreement”), that provides for a $1.0 billion unsecured revolving credit facility (the “Revolving Credit Facility”). In March of 2020, the Company drew down a total amount of $825.0 million under the Revolving Credit Facility. Borrowings under the Revolving Credit Facility are scheduled to mature on March 29, 2024, and the Company may repay amounts borrowed any time without penalty. Based on the Company’s current corporate credit ratings, the currently applicable interest rate margins are 1.0% for adjusted LIBOR rate borrowings and 0.0% for Base Rate borrowings

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	1 5 . Accumulated Other Comprehensive Income (Loss) The components of changes in accumulated other comprehensive income (loss) are as follows: Accumulated Foreign Defined Other Currency Benefit Derivative Comprehensive Adjustments Plans Agreements Income (Loss) Balance at December 31, 2018 $ (42.5 ) $ 0.9 $ (12.0 ) $ (53.6 ) Other comprehensive income (loss) before reclassifications 1.8 0.0 (10.4 ) (8.6 ) Amounts reclassified to consolidated statement of income (a) 0.0 0.0 0.0 0.0 Tax benefit (expense) 0.0 0.0 2.7 2.7 Other comprehensive income (loss) 1.8 0.0 (7.7 ) (5.9 ) Balance at March 31, 2019 $ (40.7 ) $ 0.9 $ (19.7 ) $ (59.5 ) Balance at December 31, 2019 $ (36.8 ) $ 0.0 $ (29.9 ) $ (66.7 ) Other comprehensive income (loss) before reclassifications (13.0 ) 0.0 (27.0 ) (40.0 ) Amounts reclassified to consolidated statement of income (a)(b) 0.0 0.0 1.1 1.1 Tax benefit (expense) 0.0 0.0 6.2 6.2 Other comprehensive income (loss) (13.0 ) 0.0 (19.7 ) (32.7 ) Balance at March 31, 2020 $ (49.8 ) $ 0.0 $ (49.6 ) $ (99.4 ) (a) Amounts reclassified to cost of sales, selling, general and administrative expenses or interest expense. (b) The Company reclassified a loss of $1.1 to the condensed consolidated statement of income during the three months ended March 31, 2020.

Commitments, Contingencies and

Commitments, Contingencies and Guarantees	3 Months Ended
	Mar. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Commitments, Contingencies and Guarantees	16 . Commitments, Contingencies and Guarantees Commitments a. The Company has a partnership with a supplier of raw materials that mines and processes sodium-based mineral deposits. The Company purchases the majority of its sodium-based raw material requirements from the partnership. The partnership agreement terminates upon two years’ written notice by either partner. Under the partnership agreement, the Company has an annual commitment to purchase 240,000 tons of sodium-based raw materials at the prevailing market price. The Company is not engaged in any other material transactions with the partnership or the partner supplier. b. As of March 31, 2020, the Company had commitments of approximately $ 273.1 c. As of March 31, 2020, the Company had various guarantees and letters of credit totaling $4.2. d. In connection with the Company’s acquisition of Agro BioSciences, Inc. on January 17, 2017, the Company is obligated to pay an additional amount of up to $25.0 based on sales performance in 2019. The initial fair value of this contingent liability was $17.8, which was established in the purchase price allocation. In December 2019, the final liability, which was paid in the second quarter of 2020, was lowered to $14.2 based on 2019 sales. In connection with the Passport Acquisition, the Company is obligated to pay an additional amount of up to $25.0 based on sales performance through 2020. The initial fair value of this contingent liability was $7.3, which was established in the purchase price allocation. During the second quarter of 2019, the Company recorded a reduction in fair value of the entire $7.3 Passport contingent liability based on the revised valuation due to updated sales forecasts. The reduction was recorded in SG&A in the SPD segment. There was no change in the contingent liability in the first quarter 2020 and it will be reassessed at each balance sheet date leading up to December 31, 2020. In connection with the Flawless Acquisition, the Company is obligated to pay an additional amount of up to $425.0 based on sales performance through 2021. The initial fair value of this contingent liability was $182.0. That amount was established in the purchase price allocation. Subsequent to the date of the Flawless Acquisition, the Company decreased the estimate of the contingent consideration liability by $17.0 from $182.0 to $165.0 based on the revised valuation due to updated sales forecasts as well as the passage of time. The Company recorded a $27.0 reduction to SG&A expense within the Consumer Domestic and Consumer International Segments during the first quarter of 2020. The contingent liability is remeasured at each balance sheet date until the completion of the earn-out period. Legal proceedings e. The Company has been named as a defendant in a breach of contract action filed by Scantibodies Laboratory, Inc. (the “Plaintiff”) on April 1, 2014, in the U.S. District Court for the Southern District of New York. The complaint alleges, among other things, that the Company (i) breached two agreements for the manufacture and supply of pregnancy and ovulation test kits by switching suppliers, (ii) failed to give Plaintiff the proper notice, (iii) failed to reimburse Plaintiff for costs and expenses under the agreements and (iv) misrepresented its future requirements. The complaint seeks compensatory and punitive damages in an amount in excess of $20.0, as well as declaratory relief, statutory prejudgment interest and attorneys’ fees and costs. The Company is vigorously defending itself in this matter. On September 19, 2018, the trial court granted the Company’s motion for summary judgment, dismissing all claims brought by the Plaintiff as a matter of law. The Plaintiff appealed that decision, and the 2 nd In connection with this matter, the Company has reserved an amount that is immaterial. However, it is reasonably possible that the Company may ultimately be required to pay all or substantially all of the damages and other amounts sought by Plaintiff. f. In addition, in conjunction with the Company’s acquisition and divestiture activities, the Company entered into select guarantees and indemnifications of performance with respect to the fulfillment of the Company’s commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. Representations and warranties that survive the closing date generally survive for periods up to five years or the expiration of the applicable statutes of limitations. Potential losses under the indemnifications are generally limited to a portion of the original transaction price, or to other lesser specific dollar amounts for select provisions. With respect to sale transactions, the Company also routinely enters into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on the Company’s financial condition, results of operations and cash flows. g. In addition to the matters described above, from time to time in the ordinary course of its business the Company is the subject of, or party to, various pending or threatened legal, regulatory or governmental actions or other proceedings, including, without limitation, those relating to, intellectual property, commercial transactions, product liability, purported consumer class actions, employment matters, antitrust, environmental, health, safety and other compliance related matters. Such proceedings are generally subject to considerable uncertainty and their outcomes, and any related damages, may not be reasonably predictable or estimable. While any such proceedings could result in an adverse outcome for the Company, any such adverse outcome is not expected to have a material adverse effect on the Company’s business, financial condition, results of operations or cash flows.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	1 7 . Related Party Transactions The following summarizes the balances and transactions between the Company and Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”), in each of which the Company holds a 50% ownership interest: Armand ArmaKleen Three Months Ended Three Months Ended March 31, March 31, March 31, March 31, 2020 2019 2020 2019 Purchases by Company $ 3.3 $ 2.8 $ 0.0 $ 0.0 Sales by Company $ 0.0 $ 0.0 $ 0.3 $ 0.3 Outstanding Accounts Receivable $ 0.4 $ 0.5 $ 0.7 $ 0.8 Outstanding Accounts Payable $ 1.2 $ 1.0 $ 0.0 $ 0.0 Administration & Management Oversight Services (1) $ 0.5 $ 0.6 $ 0.5 $ 0.5 (1) Billed by the Company and recorded as a reduction of SG&A expenses.

Segments

Segments	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Segments	1 8 . Segments Segment Information The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division. These segments are determined based on differences in the nature of products and organizational and ownership structures. The Company also has a Corporate segment. Segment revenues are derived from the sale of the following products: Segment Products Consumer Domestic Household and personal care products Consumer International Primarily personal care products SPD Specialty chemical products The Corporate segment income consists of equity in earnings of affiliates. As of March 31, 2020, the Company held 50% ownership interests in each of Armand and ArmaKleen, respectively . Certain subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth in the table below. Segment net sales and income before income taxes are as follows: Consumer Consumer Domestic International SPD Corporate Total Net Sales (1) First Quarter 2020 $ 891.0 $ 198.6 $ 75.6 $ 0.0 $ 1,165.2 First Quarter 2019 784.9 186.7 73.1 0.0 1,044.7 Income before Income Taxes (2) First Quarter 2020 $ 250.8 $ 38.2 $ 8.8 $ 1.6 $ 299.4 First Quarter 2019 182.7 28.4 12.3 1.7 225.1 (1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $3.0 and $2.3 for the three months ended March 31, 2020 and March 31, 2019, respectively . (2) In determining income before income taxes, interest expense, investment earnings and certain aspects of other income and expense were allocated among segments based upon each segment’s relative income from operations. Product line revenues from external customers are as follows: Three Months Ended March 31, March 31, 2020 2019 Household Products $ 494.3 $ 443.3 Personal Care Products 396.7 341.6 Total Consumer Domestic 891.0 784.9 Total Consumer International 198.6 186.7 Total SPD 75.6 73.1 Total Consolidated Net Sales $ 1,165.2 $ 1,044.7 Household Products include laundry, deodorizing and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care and hair care products and gummy dietary supplements.

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Research and Development	The Company incurred research and development expenses in the first quarter of 2020 and 2019 of $21.7 and $20.7, respectively. These expenses are included in selling, general and administrative (“SG&A”) expenses.
New Accounting Pronouncements Adopted and Issued	Recently Adopted Accounting Pronouncements In June 2016, the FASB issued accounting guidance (with subsequent targeted amendments) which modifies the measurements of expected credit losses for certain financial instruments and financial assets, including trade receivables. This guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. The standard did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows. In March 2020, the Financial Accounting Standards Board (“FASB”) issued new accounting guidance intended to provide temporary optional expedients and exceptions to the US GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates. This guidance is effective beginning on March 12, 2020, and the Company may apply the amendments prospectively to contract modifications made or relationships entered into or evaluated through December 31, 2022. The Company is currently evaluating contracts and the optional expedients provided by the new standard. There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.
Earnings Per Share ("EPS")	Basic EPS is calculated based on income available to holders of the Company’s common stock (“Common Stock”) and the weighted average number of shares outstanding during the reported period. Diluted EPS includes additional dilution from potential Common Stock issuable pursuant to the exercise of outstanding stock options. The following table sets forth a reconciliation of the weighted average number of shares of Common Stock outstanding to the weighted average number of shares outstanding on a diluted basis: Three Months Ended March 31, March 31, 2020 2019 Weighted average common shares outstanding - basic 245.6 246.1 Dilutive effect of stock options 5.4 5.8 Weighted average common shares outstanding - diluted 251.0 251.9 Antidilutive stock options outstanding 1.5 0.1

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
Components of Inventories	Inventories consist of the following: March 31, December 31, 2020 2019 Raw materials and supplies $ 85.0 $ 85.9 Work in process 30.4 29.0 Finished goods 280.3 302.5 Total $ 395.7 $ 417.4

Property, Plant and Equipment_2

Property, Plant and Equipment, Net ("PP&E") (Tables)	3 Months Ended
	Mar. 31, 2020
Property Plant And Equipment [Abstract]
Components of Property, Plant and Equipment	PP&E consists of the following: March 31, December 31, 2020 2019 Land $ 27.7 $ 27.8 Buildings and improvements 256.0 255.4 Machinery and equipment 739.4 737.4 Software 98.2 96.7 Office equipment and other assets 78.9 76.0 Construction in progress 72.0 72.9 Gross PP&E 1,272.2 1,266.2 Less accumulated depreciation and amortization 705.5 693.2 Net PP&E $ 566.7 $ 573.0 Three Months Ended March 31, March 31, 2020 2019 Depreciation and amortization on PP&E $ 16.0 $ 15.8

Earnings Per Share ("EPS") (Tab

Earnings Per Share ("EPS") (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Reconciliation Of Weighted Average Number Of Common Shares Outstanding	The following table sets forth a reconciliation of the weighted average number of shares of Common Stock outstanding to the weighted average number of shares outstanding on a diluted basis: Three Months Ended March 31, March 31, 2020 2019 Weighted average common shares outstanding - basic 245.6 246.1 Dilutive effect of stock options 5.4 5.8 Weighted average common shares outstanding - diluted 251.0 251.9 Antidilutive stock options outstanding 1.5 0.1

Stock Based Compensation Plans

Stock Based Compensation Plans (Tables)	3 Months Ended
	Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summary of Option Activity	The following table provides a summary of option activity: Weighted Average Weighted Remaining Average Contractual Aggregate Exercise Term Intrinsic Options Price (in Years) Value Outstanding at December 31, 2019 14.0 $ 43.23 Exercised (0.3 ) 29.31 Outstanding at March 31, 2020 13.7 $ 43.62 5.2 $ 300.3 Exercisable at March 31, 2020 8.4 $ 34.47 3.6 $ 250.5
Information Regarding Intrinsic Value of Stock Options Exercised and Stock Compensation Expense Related to Stock Option Awards	The following table provides information regarding the intrinsic value of stock options exercised and stock compensation expense related to stock option awards: Three Months Ended March 31, March 31, 2020 2019 Intrinsic Value of Stock Options Exercised $ 14.3 $ 24.1 Stock Compensation Expense Related to Stock Option Awards $ 2.7 $ 2.3

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Carrying Amounts and Estimated Fair Values of Other Financial Instruments	The following table presents the carrying amounts and estimated fair values of the Company’s other financial instruments at March 31, 2020 and December 31, 2019: March 31, 2020 December 31, 2019 Input Carrying Fair Carrying Fair Level Amount Value Amount Value Financial Assets: Cash equivalents Level 1 $ 963.0 $ 963.0 $ 65.3 $ 65.3 Financial Liabilities: Short-term borrowings Level 2 971.9 971.9 252.9 252.9 Term loan due May 1, 2022 Level 2 300.0 300.0 300.0 300.0 2.45% Senior notes due August 1, 2022 Level 2 299.8 296.9 299.8 302.6 2.875% Senior notes due October 1, 2022 Level 2 399.9 400.6 399.9 408.2 3.15% Senior notes due August 1, 2027 Level 2 424.7 424.8 424.7 438.9 3.95% Senior notes due August 1, 2047 Level 2 397.3 413.3 397.3 427.1 Business Acquisition Liabilities Level 3 165.0 165.0 206.2 206.2 Interest Rate Swap Lock Agreement asset (liability) Level 2 (66.4 ) (66.4 ) (29.5 ) (29.5 )

Derivative Instruments and Ri_2

Derivative Instruments and Risk Management (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts	The notional amount of a derivative instrument is the nominal or face amount used to calculate payments made on that instrument. Notional amounts are presented in the following table: Notional Notional Amount Amount March 31, 2020 December 31, 2019 Derivatives designated as hedging instruments Foreign exchange contracts $ 223.6 $ 216.0 Interest rate swap lock $ 300.0 $ 300.0 Diesel fuel contracts 7.0 gallons 4.8 gallons Commodities contracts 88.2 pounds 81.2 pounds Derivatives not designated as hedging instruments Equity derivatives $ 20.2 $ 22.1

Acquisition (Tables)

Acquisition (Tables)	3 Months Ended
	Mar. 31, 2020
Flawless Acquisition
Fair Values of Assets Acquired	The fair values of the net assets acquired are set forth as follows: Trade name $ 447.3 Other intangible assets 121.8 Goodwill 87.9 Contingent consideration (182.0 ) Cash purchase price $ 475.0

Goodwill and Other Intangible_2

Goodwill and Other Intangibles, Net (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Amortizable Intangible Assets	The following table provides information related to the carrying value of all intangible assets, other than goodwill: March 31, 2020 December 31, 2019 Gross Amortization Gross Carrying Accumulated Period Carrying Accumulated Amount Amortization Net (Years) Amount Amortization Net Amortizable intangible assets: Trade Names $ 1,019.9 $ (229.2 ) $ 790.7 3-20 $ 1,025.8 $ (219.7 ) $ 806.1 Customer Relationships 584.8 (264.0 ) 320.8 15-20 584.8 (255.0 ) 329.8 Patents/Formulas 211.4 (76.0 ) 135.4 4-20 211.4 (73.0 ) 138.4 Non-Compete Agreement 0.0 0.0 0.0 5-10 0.4 (0.4 ) 0.0 Total $ 1,816.1 $ (569.2 ) $ 1,246.9 $ 1,822.4 $ (548.1 ) $ 1,274.3
Indefinite Lived Intangible Assets	Indefinite Lived Intangible Assets - Gross Carrying Amount March 31, December 31, 2020 2019 Trade Names $ 1,474.7 $ 1,475.7
Carrying Amount of Goodwill	The carrying amount of goodwill is as follows: Consumer Consumer Specialty Domestic International Products Total Balance at December 31, 2019 $ 1,707.9 $ 235.6 $ 136.0 $ 2,079.5 Perl Weiss divestiture 0.0 (1.3 ) 0.0 (1.3 ) Balance at March 31, 2020 $ 1,707.9 $ 234.3 $ 136.0 $ 2,078.2

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Summary of Lease Information	A summary of the Company’s lease information is as follows: March 31, December 31, Classification 2020 2019 Assets Right of use assets Other Assets $ 155.2 $ 150.7 Liabilities Current lease liabilities Accounts Payable and Accrued Expenses $ 16.5 $ 16.4 Long-term lease liabilities Deferred and Other Long-term Liabilities 148.6 144.0 Total lease liabilities $ 165.1 $ 160.4 Other information Weighted-average remaining lease term (years) 11.2 11.1 Weighted-average discount rate 4.9 % 4.9 % Three Months Three Months Ended Ended March 31, 2020 March 31, 2019 Statement of Income Lease cost (1) $ 6.6 $ 5.6 Other information Leased assets obtained in exchange for new lease liabilities (2) $ 10.2 $ 1.3 Cash paid for amounts included in the measurement of lease liabilities $ 6.2 $ 6.0 (1) Lease expense is included in cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The noncash component of lease expense for the first three months of 2020 and 2019 was $4.8 and $4.1, respectively, and is included in the Amortization caption in the condensed consolidated statement of cash flows. (2) In March 2020, the Company approved a capital project to purchase additional machinery and equipment at one of its leased manufacturing facilities. This led to a lease modification to include a renewal option that would extend the lease for an additional five years through 2029. The modification resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $7.3 recorded in the first quarter of 2020.
Summary of Minimum Annual Rentals Including Reasonably Assured Renewal Options under Lease Agreements	The Company’s minimum annual rentals including reasonably assured renewal options under lease agreements are as follows: Operating Leases 2020 $ 17.5 2021 24.0 2022 21.6 2023 16.8 2024 15.6 2025 and thereafter 120.5 Total future minimum lease commitments 216.0 Less: Imputed Interest (50.9 ) Present value of lease liabilities $ 165.1

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	3 Months Ended
	Mar. 31, 2020
Payables And Accruals [Abstract]
Accounts Payable and Accrued Expenses	Accounts payable and accrued expenses consist of the following: March 31, December 31, 2020 2019 Trade accounts payable $ 460.1 $ 473.3 Accrued marketing and promotion costs 123.9 138.1 Accrued wages and related benefit costs 37.6 96.5 Other accrued current liabilities 119.6 124.0 Total $ 741.2 $ 831.9

Short-Term Borrowings and Lon_2

Short-Term Borrowings and Long-Term Debt (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Components of Short-Term Borrowings and Long-Term Debt	Short-term borrowings and long-term debt consist of the following: March 31, December 31, 2020 2019 Short-term borrowings Revolving credit agreement borrowings (a) $ 825.0 $ 0.0 Commercial paper issuances 144.1 248.6 Various debt due to international banks 2.8 4.3 Total short-term borrowings $ 971.9 $ 252.9 Long-term debt Term loan due May 1, 2022 300.0 300.0 2.45% Senior notes due August 1, 2022 300.0 300.0 Less: Discount (0.2 ) (0.2 ) 2.875% Senior notes due October 1, 2022 400.0 400.0 Less: Discount (0.1 ) (0.1 ) 3.15% Senior notes due August 1, 2027 425.0 425.0 Less: Discount (0.3 ) (0.3 ) 3.95% Senior notes due August 1, 2047 400.0 400.0 Less: Discount (2.7 ) (2.7 ) Debt issuance costs, net (10.9 ) (11.5 ) Net long-term debt $ 1,810.8 $ 1,810.2 The Company is party to a credit agreement dated March 29, 2018, as amended (the “Credit Agreement”), that provides for a $1.0 billion unsecured revolving credit facility (the “Revolving Credit Facility”). In March of 2020, the Company drew down a total amount of $825.0 million under the Revolving Credit Facility. Borrowings under the Revolving Credit Facility are scheduled to mature on March 29, 2024, and the Company may repay amounts borrowed any time without penalty. Based on the Company’s current corporate credit ratings, the currently applicable interest rate margins are 1.0% for adjusted LIBOR rate borrowings and 0.0% for Base Rate borrowings

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Components of Changes in Accumulated Other Comprehensive Income (Loss)	The components of changes in accumulated other comprehensive income (loss) are as follows: Accumulated Foreign Defined Other Currency Benefit Derivative Comprehensive Adjustments Plans Agreements Income (Loss) Balance at December 31, 2018 $ (42.5 ) $ 0.9 $ (12.0 ) $ (53.6 ) Other comprehensive income (loss) before reclassifications 1.8 0.0 (10.4 ) (8.6 ) Amounts reclassified to consolidated statement of income (a) 0.0 0.0 0.0 0.0 Tax benefit (expense) 0.0 0.0 2.7 2.7 Other comprehensive income (loss) 1.8 0.0 (7.7 ) (5.9 ) Balance at March 31, 2019 $ (40.7 ) $ 0.9 $ (19.7 ) $ (59.5 ) Balance at December 31, 2019 $ (36.8 ) $ 0.0 $ (29.9 ) $ (66.7 ) Other comprehensive income (loss) before reclassifications (13.0 ) 0.0 (27.0 ) (40.0 ) Amounts reclassified to consolidated statement of income (a)(b) 0.0 0.0 1.1 1.1 Tax benefit (expense) 0.0 0.0 6.2 6.2 Other comprehensive income (loss) (13.0 ) 0.0 (19.7 ) (32.7 ) Balance at March 31, 2020 $ (49.8 ) $ 0.0 $ (49.6 ) $ (99.4 ) (a) Amounts reclassified to cost of sales, selling, general and administrative expenses or interest expense. (b) The Company reclassified a loss of $1.1 to the condensed consolidated statement of income during the three months ended March 31, 2020.

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following summarizes the balances and transactions between the Company and Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”), in each of which the Company holds a 50% ownership interest: Armand ArmaKleen Three Months Ended Three Months Ended March 31, March 31, March 31, March 31, 2020 2019 2020 2019 Purchases by Company $ 3.3 $ 2.8 $ 0.0 $ 0.0 Sales by Company $ 0.0 $ 0.0 $ 0.3 $ 0.3 Outstanding Accounts Receivable $ 0.4 $ 0.5 $ 0.7 $ 0.8 Outstanding Accounts Payable $ 1.2 $ 1.0 $ 0.0 $ 0.0 Administration & Management Oversight Services (1) $ 0.5 $ 0.6 $ 0.5 $ 0.5 (1) Billed by the Company and recorded as a reduction of SG&A expenses.

Segments (Tables)

Segments (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Selected Financial Information Relating To Company's Segments	Segment net sales and income before income taxes are as follows: Consumer Consumer Domestic International SPD Corporate Total Net Sales (1) First Quarter 2020 $ 891.0 $ 198.6 $ 75.6 $ 0.0 $ 1,165.2 First Quarter 2019 784.9 186.7 73.1 0.0 1,044.7 Income before Income Taxes (2) First Quarter 2020 $ 250.8 $ 38.2 $ 8.8 $ 1.6 $ 299.4 First Quarter 2019 182.7 28.4 12.3 1.7 225.1 (1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $3.0 and $2.3 for the three months ended March 31, 2020 and March 31, 2019, respectively . (2) In determining income before income taxes, interest expense, investment earnings and certain aspects of other income and expense were allocated among segments based upon each segment’s relative income from operations.
Product Line Revenues From External Customers	Product line revenues from external customers are as follows: Three Months Ended March 31, March 31, 2020 2019 Household Products $ 494.3 $ 443.3 Personal Care Products 396.7 341.6 Total Consumer Domestic 891.0 784.9 Total Consumer International 198.6 186.7 Total SPD 75.6 73.1 Total Consolidated Net Sales $ 1,165.2 $ 1,044.7

Basis of Presentation - Additio

Basis of Presentation - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Research and development expenses	$ 21.7	$ 20.7

Components of Inventories (Deta

Components of Inventories (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Inventory, Finished Goods and Work in Process, Net of Reserves [Abstract]
Raw materials and supplies	$ 85	$ 85.9
Work in process	30.4	29
Finished goods	280.3	302.5
Total	$ 395.7	$ 417.4

Components of Property, Plant a

Components of Property, Plant and Equipment (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Gross PP&E	$ 1,272.2	$ 1,266.2
Less accumulated depreciation and amortization	705.5	693.2
Net PP&E	566.7	573
Land
Property, Plant and Equipment [Line Items]
Gross PP&E	27.7	27.8
Building and Building Improvements
Property, Plant and Equipment [Line Items]
Gross PP&E	256	255.4
Machinery and Equipment
Property, Plant and Equipment [Line Items]
Gross PP&E	739.4	737.4
Software
Property, Plant and Equipment [Line Items]
Gross PP&E	98.2	96.7
Office equipment and other assets
Property, Plant and Equipment [Line Items]
Gross PP&E	78.9	76
Construction in progress
Property, Plant and Equipment [Line Items]
Gross PP&E	$ 72	$ 72.9

Depreciation and Interest Charg

Depreciation and Interest Charges on Property, Plant and Equipment (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Property Plant And Equipment [Abstract]
Depreciation and amortization on PP&E	$ 16	$ 15.8

Reconciliation of Weighted Aver

Reconciliation of Weighted Average Number of Shares of Common Stock Outstanding (Details) - shares shares in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Weighted average shares outstanding - Basic	245.6	246.1
Dilutive effect of stock options	5.4	5.8
Weighted average common shares outstanding - diluted	251	251.9
Antidilutive stock options outstanding	1.5	0.1

Summary of Option Activity (Det

Summary of Option Activity (Details) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)$ / sharesshares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Beginning Balance, Options | shares	14
Exercised, Options | shares	(0.3)
Ending Balance, Options | shares	13.7
Exercisable at March 31, 2020, Options | shares	8.4
Beginning Balance, Weighted-Average Exercise Price | $ / shares	$ 43.23
Exercised, Weighted-Average Exercise Price | $ / shares	29.31
Ending Balance, Weighted-Average Exercise Price | $ / shares	43.62
Exercisable at March 31, 2020 Weighted-Average Exercise Price | $ / shares	$ 34.47
Outstanding at March 31, 2020, Weighted-Average Remaining Contractual Term, years	5 years 2 months 12 days
Exercisable at March 31, 2020, Weighted-Average Remaining Contractual Term, years	3 years 7 months 6 days
Outstanding at March 31, 2020, Aggregate Intrinsic Value | $	$ 300.3
Exercisable at March 31, 2020, Aggregate Intrinsic Value | $	$ 250.5

Schedule of Share Based Compens

Schedule of Share Based Compensation Stock Options (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Intrinsic Value of Stock Options Exercised	$ 14.3	$ 24.1
Stock Compensation Expense Related to Stock Option Awards	$ 2.7	$ 2.3

Share Repurchases - Additional

Share Repurchases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Nov. 01, 2017
Equity Class Of Treasury Stock [Line Items]
Stock repurchase program, authorized amount		$ 500
Shares repurchase	0
Repurchase Program
Equity Class Of Treasury Stock [Line Items]
Remaining amount of share repurchase program	$ 210

Carrying Amounts and Estimated

Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Short-term borrowings	$ 971.9	$ 252.9
Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Cash equivalents	963	65.3
Short-term borrowings	971.9	252.9
Business Acquisition Liabilities	165	206.2
Fair Value | Fair Value, Inputs, Level 1
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Cash equivalents	963	65.3
Fair Value | Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Short-term borrowings	971.9	252.9
Fair Value | Fair Value, Inputs, Level 3
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Business Acquisition Liabilities	165	206.2
Interest Rate Swap Lock Agreement Asset (Liability) | Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest Rate Swap Lock Agreement asset (liability)	(66.4)	(29.5)
Interest Rate Swap Lock Agreement Asset (Liability) | Fair Value | Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest Rate Swap Lock Agreement asset (liability)	(66.4)	(29.5)
Term Loan Due May 1, 2022 | Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Term loan	300	300
Term Loan Due May 1, 2022 | Fair Value | Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Term loan	300	300
2.45% Senior notes due August 1, 2022 | Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior Notes	299.8	299.8
2.45% Senior notes due August 1, 2022 | Fair Value | Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior notes	296.9	302.6
2.875% Senior notes due October 1, 2022 | Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior Notes	399.9	399.9
2.875% Senior notes due October 1, 2022 | Fair Value | Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior notes	400.6	408.2
3.15% Senior notes due August 1, 2027 | Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior Notes	424.7	424.7
3.15% Senior notes due August 1, 2027 | Fair Value | Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior notes	424.8	438.9
3.95% Senior notes due August 1, 2047 | Carrying Amount
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior Notes	397.3	397.3
3.95% Senior notes due August 1, 2047 | Fair Value | Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Senior notes	$ 413.3	$ 427.1

Carrying Amounts and Estimate_2

Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Parenthetical) (Details)	Mar. 31, 2020	Dec. 31, 2019
2.45% Senior notes due August 1, 2022
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	2.45%	2.45%
2.45% Senior notes due August 1, 2022 | Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	2.45%	2.45%
2.875% Senior notes due October 1, 2022
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	2.875%	2.875%
2.875% Senior notes due October 1, 2022 | Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	2.875%	2.875%
3.15% Senior notes due August 1, 2027
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	3.15%	3.15%
3.15% Senior notes due August 1, 2027 | Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	3.15%	3.15%
3.95% Senior notes due August 1, 2047
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	3.95%	3.95%
3.95% Senior notes due August 1, 2047 | Fair Value, Inputs, Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Interest rate of debt	3.95%	3.95%

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended	11 Months Ended
	Mar. 31, 2020	Mar. 31, 2020	Dec. 31, 2019	May 01, 2019	Jan. 17, 2017
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Increase in interest rate swap lock agreements liability	$ 36.9	$ 36.9
Consumer Domestic and Consumer International Segment
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Increase (decrease) in estimate of contingent consideration liability	(27)
Flawless Acquisition
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Business Acquisition Liabilities			$ 192	$ 182
Flawless Acquisition | Updated Sales Forecasts
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Business Acquisition Liabilities	165	165
Increase (decrease) in estimate of contingent consideration liability	$ (27)	$ (17)
Agro Bio Sciences Inc
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Business Acquisition Liabilities					$ 17.8
Agro Bio Sciences Inc | Updated Sales Forecasts
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Business Acquisition Liabilities			$ 14.2

Schedule of Notional Amounts (D

Schedule of Notional Amounts (Details) lb in Millions, gal in Millions, $ in Millions	Mar. 31, 2020USD ($)gallb	Dec. 31, 2019USD ($)gallb
Designated as Hedging Instrument | Foreign Exchange Contract
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivatives, Notional Amount	$ 223.6	$ 216
Designated as Hedging Instrument | Interest Rate Swap Lock
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivatives, Notional Amount	$ 300	$ 300
Designated as Hedging Instrument | Diesel fuel contracts
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivatives, Notional Amount, Volume | gal	7	4.8
Designated as Hedging Instrument | Commodities Contracts
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivatives, Notional Amount, Volume | lb	88.2	81.2
Not Designated as Hedging Instrument | Equity derivatives
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivatives, Notional Amount	$ 20.2	$ 22.1

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details) - Flawless Acquisition - USD ($)	May 01, 2019	Mar. 31, 2020	Mar. 31, 2020	Dec. 31, 2019
Business Acquisition [Line Items]
Purchase price paid at closing	$ 475,000,000
Commercial paper borrowings and loan term	3 years
Net sales target period	12 months
Net sales target ending date	Dec. 31, 2021
Business Acquisition Liabilities	$ 182,000,000			$ 192,000,000
Updated Sales Forecasts
Business Acquisition [Line Items]
Increase (decrease) in estimate of contingent consideration liability		$ (27,000,000)	$ (17,000,000)
Business Acquisition Liabilities		$ 165,000,000	$ 165,000,000
Maximum
Business Acquisition [Line Items]
Additional earn-out payment	$ 425,000,000
Average life of the amortizable intangible assets, years	20 years
Minimum
Business Acquisition [Line Items]
Average life of the amortizable intangible assets, years	15 years

Fair Values of Net Assets Acqui

Fair Values of Net Assets Acquired (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	May 01, 2019
Business Acquisition [Line Items]
Goodwill	$ 2,078.2	$ 2,079.5
Flawless Acquisition
Business Acquisition [Line Items]
Trade name			$ 447.3
Other intangible assets			121.8
Goodwill			87.9
Contingent consideration		$ (192)	(182)
Cash purchase price			$ 475

Amortizable Intangible Assets (

Amortizable Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 1,816.1	$ 1,822.4
Accumulated Amortization	(569.2)	(548.1)
Net	1,246.9	1,274.3
Trade Names
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,019.9	1,025.8
Accumulated Amortization	(229.2)	(219.7)
Net	$ 790.7	806.1
Trade Names | Minimum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	3 years
Trade Names | Maximum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	20 years
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 584.8	584.8
Accumulated Amortization	(264)	(255)
Net	$ 320.8	329.8
Customer Relationships | Minimum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	15 years
Customer Relationships | Maximum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	20 years
Patents
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 211.4	211.4
Accumulated Amortization	(76)	(73)
Net	$ 135.4	138.4
Patents | Minimum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	4 years
Patents | Maximum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	20 years
Noncompete Agreements
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 0	0.4
Accumulated Amortization	0	(0.4)
Net	$ 0	$ 0
Noncompete Agreements | Minimum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	5 years
Noncompete Agreements | Maximum
Finite-Lived Intangible Assets [Line Items]
Amortization Period (Years)	10 years

Indefinite Lived Intangible Ass

Indefinite Lived Intangible Assets (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Trade Names
Indefinite-lived Intangible Assets [Line Items]
Gross Carrying Amount, Trade names	$ 1,474.7	$ 1,475.7

Goodwill and Other Intangible_3

Goodwill and Other Intangibles, Net - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Amortization expense of intangible assets	$ 24.5	$ 17.6
Estimated amortization expense, 2020	98
Cash proceeds for sale of business	7	0
Gain on sale of business	3	$ 0
Gross Carrying Amount	1,816.1		$ 1,822.4
Percent of fair value in excess of carrying value			26.00%
Average royalty rate			10.00%
Net book value	1,246.9		$ 1,274.3
U.S
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Fair value assumptions discount rate			9.50%
International
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Fair value assumptions discount rate			11.50%
Trade Names
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Gross Carrying Amount	1,019.9		$ 1,025.8
Net book value	790.7		806.1
Trojan Trade Name
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Gross Carrying Amount			$ 176.4
Trade Name and Other Intangible Assets
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Net book value	$ 24
Remaining amortization period	12 years
PERL WEISS Toothpaste
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Goodwill	$ 1.3
Cash proceeds for sale of business	$ 7
Discontinued Operation, Name of Segment [Extensible List]	chd:ConsumerInternationalSegmentMember
PERL WEISS Toothpaste | Selling General and Administrative Expenses
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Gain on sale of business	$ 3
PERL WEISS Toothpaste | Trade Names
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Net book value of trade name	2.7
Maximum
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Estimated amortization expense, 2021	96
Estimated amortization expense, 2022	96
Estimated amortization expense, 2023	96
Estimated amortization expense, 2024	96
Estimated amortization expense, 2025	96
Fair value assumptions growth rate			2.00%
Minimum
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Estimated amortization expense, 2021	88
Estimated amortization expense, 2022	88
Estimated amortization expense, 2023	88
Estimated amortization expense, 2024	88
Estimated amortization expense, 2025	$ 88
Fair value assumptions growth rate			0.00%

Carrying Amount of Goodwill (De

Carrying Amount of Goodwill (Details) $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)
Goodwill [Line Items]
Beginning balance	$ 2,079.5
Ending balance	2,078.2
PERL WEISS Toothpaste
Goodwill [Line Items]
Perl Weiss divestiture	(1.3)
Consumer Domestic
Goodwill [Line Items]
Beginning balance	1,707.9
Ending balance	1,707.9
Consumer Domestic | PERL WEISS Toothpaste
Goodwill [Line Items]
Perl Weiss divestiture	0
Consumer International
Goodwill [Line Items]
Beginning balance	235.6
Ending balance	234.3
Consumer International | PERL WEISS Toothpaste
Goodwill [Line Items]
Perl Weiss divestiture	(1.3)
Specialty Products
Goodwill [Line Items]
Beginning balance	136
Ending balance	136
Specialty Products | PERL WEISS Toothpaste
Goodwill [Line Items]
Perl Weiss divestiture	$ 0

Summary of Lease Information (D

Summary of Lease Information (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Leases [Abstract]
Right of use assets		$ 155.2		$ 150.7
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]				us-gaap:OtherAssetsNoncurrent
Current lease liabilities		16.5		$ 16.4
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]				us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
Long-term lease liabilities		148.6		$ 144
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]				us-gaap:OtherLiabilitiesNoncurrent
Total lease liabilities		$ 165.1		$ 160.4
Weighted-average remaining lease term (years)		11 years 2 months 12 days		11 years 1 month 6 days
Weighted-average discount rate		4.90%		4.90%
Lease cost	[1]	$ 6.6	$ 5.6
Leased assets obtained in exchange for new lease liabilities(2)	[2]	10.2	1.3
Cash paid for amounts included in the measurement of lease liabilities		$ 6.2	$ 6
[1]	Lease expense is included in cost of sales or SG&A expenses based on the nature of the leased item.  Short-term lease expense is excluded from this amount and is not material.  The Company also has certain variable leases which are not material.  The noncash component of lease expense for the first three months of 2020 and 2019 was $4.8 and $4.1, respectively, and is included in the Amortization caption in the condensed consolidated statement of cash flows.
[2]	In March 2020, the Company approved a capital project to purchase additional machinery and equipment at one of its leased manufacturing facilities. This led to a lease modification to include a renewal option that would extend the lease for an additional five years through 2029.  The modification resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $7.3 recorded in the first quarter of 2020.

Summary of Lease information (P

Summary of Lease information (Parenthetical) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Noncash component of lease expense	$ 4.8	$ 4.1
Lease extension term	5 years
Lease expiration period	2029
Increase (decrease) in right-of-use asset	$ 7.3
Increase (decrease) in operating lease liabilities	$ 7.3

Summary of Minimum Annual Renta

Summary of Minimum Annual Rentals Including Reasonably Assured Renewal Options under Lease Agreements (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Operating Leases
2020	$ 17.5
2021	24
2022	21.6
2023	16.8
2024	15.6
2025 and thereafter	120.5
Total future minimum lease commitments	216
Less: Imputed Interest	(50.9)
Present value of lease liabilities	$ 165.1	$ 160.4

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Accounts Payable and Accrued Liabilities, Current [Abstract]
Trade accounts payable	$ 460.1	$ 473.3
Accrued marketing and promotion costs	123.9	138.1
Accrued wages and related benefit costs	37.6	96.5
Other accrued current liabilities	119.6	124
Total	$ 741.2	$ 831.9

Summary of Short-Term Borrowing

Summary of Short-Term Borrowings and Long-Term Debt (Details) - USD ($) $ in Millions		Mar. 31, 2020	Dec. 31, 2019
Short-term borrowings
Revolving credit agreement borrowings	[1]	$ 825	$ 0
Commercial paper issuances		144.1	248.6
Various debt due to international banks		2.8	4.3
Total short-term borrowings		971.9	252.9
Long-term debt
Debt issuance costs, net		(10.9)	(11.5)
Net long-term debt		1,810.8	1,810.2
Term Loan
Long-term debt
Term loan		300	300
2.45% Senior notes due August 1, 2022
Long-term debt
Senior notes		300	300
Less: Discount		(0.2)	(0.2)
2.875% Senior notes due October 1, 2022
Long-term debt
Senior notes		400	400
Less: Discount		(0.1)	(0.1)
3.15% Senior notes due August 1, 2027
Long-term debt
Senior notes		425	425
Less: Discount		(0.3)	(0.3)
3.95% Senior notes due August 1, 2047
Long-term debt
Senior notes		400	400
Less: Discount		$ (2.7)	$ (2.7)
[1]	The Company is party to a credit agreement dated March 29, 2018, as amended (the “Credit Agreement”), that provides for a $1.0 billion unsecured revolving credit facility (the “Revolving Credit Facility”). In March of 2020, the Company drew down a total amount of $825.0 million under the Revolving Credit Facility. Borrowings under the Revolving Credit Facility are scheduled to mature on March 29, 2024, and the Company may repay amounts borrowed any time without penalty. Based on the Company’s current corporate credit ratings, the currently applicable interest rate margins are 1.0% for adjusted LIBOR rate borrowings and 0.0% for Base Rate borrowings

Summary of Short-Term Borrowi_2

Summary of Short-Term Borrowings and Long-Term Debt (Parenthetical) (Details) - USD ($) $ in Millions		3 Months Ended	12 Months Ended
		Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Amount borrowed under unsecured revolving credit facility	[1]	$ 825	$ 0
Unsecured Revolving Credit Facility
Debt Instrument [Line Items]
Maturity date of debt		Mar. 29, 2024
Unsecured revolving credit facility		$ 1,000
Amount borrowed under unsecured revolving credit facility		$ 825
Unsecured Revolving Credit Facility | LIBOR Rate
Debt Instrument [Line Items]
Debt instrument interest rate		1.00%
Unsecured Revolving Credit Facility | Base Rate
Debt Instrument [Line Items]
Debt instrument interest rate		0.00%
2.45% Senior notes due August 1, 2022
Debt Instrument [Line Items]
Interest rate of debt		2.45%	2.45%
Maturity date of debt		Aug. 1, 2022	Aug. 1, 2022
2.875% Senior notes due October 1, 2022
Debt Instrument [Line Items]
Interest rate of debt		2.875%	2.875%
Maturity date of debt		Oct. 1, 2022	Oct. 1, 2022
3.15% Senior notes due August 1, 2027
Debt Instrument [Line Items]
Interest rate of debt		3.15%	3.15%
Maturity date of debt		Aug. 1, 2027	Aug. 1, 2027
3.95% Senior notes due August 1, 2047
Debt Instrument [Line Items]
Interest rate of debt		3.95%	3.95%
Maturity date of debt		Aug. 1, 2047	Aug. 1, 2047
Term Loan
Debt Instrument [Line Items]
Maturity date of debt		May 1, 2022	May 1, 2022
[1]	The Company is party to a credit agreement dated March 29, 2018, as amended (the “Credit Agreement”), that provides for a $1.0 billion unsecured revolving credit facility (the “Revolving Credit Facility”). In March of 2020, the Company drew down a total amount of $825.0 million under the Revolving Credit Facility. Borrowings under the Revolving Credit Facility are scheduled to mature on March 29, 2024, and the Company may repay amounts borrowed any time without penalty. Based on the Company’s current corporate credit ratings, the currently applicable interest rate margins are 1.0% for adjusted LIBOR rate borrowings and 0.0% for Base Rate borrowings

Components of Changes in Accumu

Components of Changes in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2020		Mar. 31, 2019
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance		$ (66.7)		$ (53.6)
Other comprehensive income (loss) before reclassifications		(40)		(8.6)
Amounts reclassified to consolidated statement of income	[2]	1.1	[1]	0
Tax benefit (expense)		6.2		2.7
Other comprehensive income (loss)		(32.7)		(5.9)
Ending balance		(99.4)		(59.5)
Foreign Currency Adjustments
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance		(36.8)		(42.5)
Other comprehensive income (loss) before reclassifications		(13)		1.8
Amounts reclassified to consolidated statement of income	[2]	0	[1]	0
Tax benefit (expense)		0		0
Other comprehensive income (loss)		(13)		1.8
Ending balance		(49.8)		(40.7)
Defined Benefit Plans
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance		0		0.9
Other comprehensive income (loss) before reclassifications		0		0
Amounts reclassified to consolidated statement of income	[2]	0	[1]	0
Tax benefit (expense)		0		0
Other comprehensive income (loss)		0		0
Ending balance		0		0.9
Derivative Agreements
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance		(29.9)		(12)
Other comprehensive income (loss) before reclassifications		(27)		(10.4)
Amounts reclassified to consolidated statement of income	[2]	1.1	[1]	0
Tax benefit (expense)		6.2		2.7
Other comprehensive income (loss)		(19.7)		(7.7)
Ending balance		$ (49.6)		$ (19.7)
[1]	The Company reclassified a loss of $1.1 to the condensed consolidated statement of income during the three months ended March 31, 2020.
[2]	Amounts reclassified to cost of sales, selling, general and administrative expenses or interest expense.

Components of Changes in Accu_2

Components of Changes in Accumulated Other Comprehensive Income (Loss) (Parenthetical) (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2020		Mar. 31, 2019
Statement Of Stockholders Equity [Abstract]
Amounts loss (gain) reclassified to condensed consolidated statement of income	[2]	$ 1.1	[1]	$ 0
[1]	The Company reclassified a loss of $1.1 to the condensed consolidated statement of income during the three months ended March 31, 2020.
[2]	Amounts reclassified to cost of sales, selling, general and administrative expenses or interest expense.

Commitments, Contingencies an_2

Commitments, Contingencies and Guarantees - Additional Information (Details)	May 01, 2019USD ($)	Mar. 08, 2018USD ($)	Jan. 17, 2017USD ($)	Mar. 31, 2020USD ($)T	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Jun. 30, 2019USD ($)
Commitments And Contingencies Disclosure [Line Items]
Annual purchase commitment, in tons | T				240,000
Commitments				$ 273,100,000
Outstanding guarantees and letters of credit				4,200,000	$ 4,200,000
Estimated minimum compensatory punitive damages				20,000,000
Agro Bio Sciences Inc
Commitments And Contingencies Disclosure [Line Items]
Payment year of achieving certain operating performance			2019
Payment to be made if certain operating performance is achieved			$ 17,800,000
Passport Food Safety Solutions Inc
Commitments And Contingencies Disclosure [Line Items]
Payment year of achieving certain operating performance		2020
Payment to be made if certain operating performance is achieved		$ 7,300,000
Increase (decrease) in estimate of contingent consideration liability				0
Flawless Acquisition
Commitments And Contingencies Disclosure [Line Items]
Payment year of achieving certain operating performance	2021
Payment to be made if certain operating performance is achieved	$ 182,000,000					$ 192,000,000
Consumer Domestic and Consumer International Segment
Commitments And Contingencies Disclosure [Line Items]
Increase (decrease) in estimate of contingent consideration liability				27,000,000
Maximum | Agro Bio Sciences Inc
Commitments And Contingencies Disclosure [Line Items]
Additional earn-out payment			$ 25,000,000
Maximum | Passport Food Safety Solutions Inc
Commitments And Contingencies Disclosure [Line Items]
Additional earn-out payment		$ 25,000,000
Maximum | Flawless Acquisition
Commitments And Contingencies Disclosure [Line Items]
Additional earn-out payment	$ 425,000,000
Updated Sales Forecasts | Agro Bio Sciences Inc
Commitments And Contingencies Disclosure [Line Items]
Payment to be made if certain operating performance is achieved						$ 14,200,000
Updated Sales Forecasts | Passport Food Safety Solutions Inc
Commitments And Contingencies Disclosure [Line Items]
Reversed contingent liability							$ 7,300,000
Updated Sales Forecasts | Flawless Acquisition
Commitments And Contingencies Disclosure [Line Items]
Payment to be made if certain operating performance is achieved				165,000,000	165,000,000
Increase (decrease) in estimate of contingent consideration liability				$ (27,000,000)	$ (17,000,000)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details)	Mar. 31, 2020	Mar. 31, 2019
Armand Products Company
Related Party Transaction [Line Items]
Percentage of ownership interest	50.00%	50.00%
ArmaKleen Company
Related Party Transaction [Line Items]
Percentage of ownership interest	50.00%	50.00%

Balance and Transactions Betwee

Balance and Transactions Between Company and Related Party (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Armand Products Company
Related Party Transaction [Line Items]
Purchases by Company		$ 3.3	$ 2.8
Sales by Company		0	0
Outstanding Accounts Receivable		0.4	0.5
Outstanding Accounts Payable		1.2	1
Administration & Management Oversight Services	[1]	0.5	0.6
ArmaKleen Company
Related Party Transaction [Line Items]
Purchases by Company		0	0
Sales by Company		0.3	0.3
Outstanding Accounts Receivable		0.7	0.8
Outstanding Accounts Payable		0	0
Administration & Management Oversight Services	[1]	$ 0.5	$ 0.5
[1]	Billed by the Company and recorded as a reduction of SG&A expenses.

Segments - Additional Informati

Segments - Additional Information (Details) $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)Segment	Mar. 31, 2019USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | Segment	3
Equity in earnings of affiliates	$ 1.6	$ 1.7
Armand Products Company
Segment Reporting Information [Line Items]
Percentage of ownership interest	50.00%	50.00%
ArmaKleen Company
Segment Reporting Information [Line Items]
Percentage of ownership interest	50.00%	50.00%
Armand Products Company and ArmaKleen Company
Segment Reporting Information [Line Items]
Equity in earnings of affiliates	$ 1.6	$ 1.7

Selected Financial Information

Selected Financial Information Relating To Company's Segments (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Net Sales	[1]	$ 1,165.2	$ 1,044.7
Income Before Income Taxes	[2]	299.4	225.1
Operating Segments | Consumer Domestic
Segment Reporting Information [Line Items]
Net Sales	[1]	891	784.9
Income Before Income Taxes	[2]	250.8	182.7
Operating Segments | Consumer International
Segment Reporting Information [Line Items]
Net Sales	[1]	198.6	186.7
Income Before Income Taxes	[2]	38.2	28.4
Operating Segments | Specialty Products
Segment Reporting Information [Line Items]
Net Sales	[1]	75.6	73.1
Income Before Income Taxes	[2]	8.8	12.3
Corporate
Segment Reporting Information [Line Items]
Net Sales	[1]	0	0
Income Before Income Taxes	[2]	$ 1.6	$ 1.7
[1]	Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $3.0 and $2.3 for the three months ended March 31, 2020 and March 31, 2019, respectively .
[2]	In determining income before income taxes, interest expense, investment earnings and certain aspects of other income and expense were allocated among segments based upon each segment’s relative income from operations.

Selected Financial Informatio_2

Selected Financial Information Relating To Company's Segments (Parenthetical) (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Net Sales	[1]	$ 1,165.2	$ 1,044.7
Intersegment Sales
Segment Reporting Information [Line Items]
Net Sales		$ 3	$ 2.3
[1]	Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $3.0 and $2.3 for the three months ended March 31, 2020 and March 31, 2019, respectively .

Product Line Revenues from Exte

Product Line Revenues from External Customers (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Net Sales	[1]	$ 1,165.2	$ 1,044.7
Operating Segments | Consumer Domestic
Segment Reporting Information [Line Items]
Net Sales	[1]	891	784.9
Operating Segments | Consumer Domestic | Household Products
Segment Reporting Information [Line Items]
Net Sales		494.3	443.3
Operating Segments | Consumer Domestic | Personal Care Products
Segment Reporting Information [Line Items]
Net Sales		396.7	341.6
Operating Segments | Consumer International
Segment Reporting Information [Line Items]
Net Sales	[1]	198.6	186.7
Operating Segments | Specialty Products
Segment Reporting Information [Line Items]
Net Sales	[1]	$ 75.6	$ 73.1
[1]	Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $3.0 and $2.3 for the three months ended March 31, 2020 and March 31, 2019, respectively .